We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+12.85%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$525B
AUM Growth
+$44.8B
Cap. Flow
-$12.4B
Cap. Flow %
-2.36%
Top 10 Hldgs %
23.82%
Holding
13,823
New
1,903
Increased
5,066
Reduced
5,122
Closed
1,577

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.23%
2 Technology 2.06%
3 Consumer Discretionary 1.41%
4 Healthcare 0.83%
5 Financials 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWH icon
11576
Sportsman's Warehouse
SPWH
$44.5M
$60.6K ﹤0.01%
14,223
-21,596
-60% -$102K
WYY icon
11577
WidePoint Corp
WYY
$101M
$60.5K ﹤0.01%
26,096
+10,249
+65% +$18.4K
RAIL icon
11578
CALL
FreightCar America
RAIL
$238M
$60.5K ﹤0.01%
22,400
+10,100
+82% +$25.5K
CTMX icon
11579
CytomX Therapeutics
CTMX
$747M
$60.4K ﹤0.01%
38,992
-49,578
-56% -$65.2K
GOSS icon
11580
CALL
Gossamer Bio
GOSS
$83.1M
$60.4K ﹤0.01%
66,400
-56,600
-46% -$41.8K
NSLR
11581
PUT
Neostellar Capital Corp
NSLR
$272M
$60.3K ﹤0.01%
15,300
-140,100
-90% -$560K
QTTB icon
11582
Q32 Bio
QTTB
$480M
$60.2K ﹤0.01%
5,505
-906
-14% -$13.2K
OKUR
11583
CALL
OnKure Therapeutics
OKUR
$156M
$60.2K ﹤0.01%
+3,760
New +$234K
CLLS
11584
Cellectis
CLLS
$353M
$60.1K ﹤0.01%
+19,524
New +$46.3K
CMLS
11585
CALL
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$60.1K ﹤0.01%
11,300
-16,500
-59% -$83.4K
ATOS icon
11586
CALL
Atossa Therapeutics
ATOS
$26.3M
$59.7K ﹤0.01%
4,520
+3,280
+265% +$35.4K
GNS icon
11587
PUT
Genius Group
GNS
$36.5M
$59.7K ﹤0.01%
9,040
-3,070
-25% -$22.4K
OGG
11588
PUT
Osisko Gold Group
OGG
$966M
$59.7K ﹤0.01%
+20,500
New +$61.8K
BHR
11589
Braemar Hotels & Resorts
BHR
$141M
$59.6K ﹤0.01%
23,826
-63,218
-73% -$157K
MCRB icon
11590
PUT
Seres Therapeutics
MCRB
$49.5M
$59.5K ﹤0.01%
2,125
+630
+42% +$16.5K
ASMB icon
11591
Assembly Biosciences
ASMB
$708M
$58.9K ﹤0.01%
+5,981
New +$56.9K
COCP icon
11592
Cocrystal Pharma
COCP
$22.2M
$58.7K ﹤0.01%
34,544
-37,635
-52% -$66.9K
CIG icon
11593
CALL
CEMIG Preferred Shares
CIG
$5.64B
$58.7K ﹤0.01%
32,890
-71,630
-69% -$130K
XXII
11594
PUT
22nd Century Group
XXII
$2.17M
0
ICMB icon
11595
Investcorp Credit Management BDC
ICMB
$12.2M
$58.6K ﹤0.01%
16,481
-8,773
-35% -$31.4K
CTRM icon
11596
CALL
Castor Maritime
CTRM
$23.7M
$58.4K ﹤0.01%
13,570
MIN
11597
Aberdeen Intermediate Income Fund
MIN
$278M
$58.3K ﹤0.01%
21,758
-22,698
-51% -$60.6K
TSHA icon
11598
PUT
Taysha Gene Therapies
TSHA
$1.94B
$58.1K ﹤0.01%
32,800
-2,500
-7% -$4.98K
AEG icon
11599
Aegon
AEG
$13.6B
$57.9K ﹤0.01%
10,054
-38,620
-79% -$201K
SGMO
11600
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$57.7K ﹤0.01%
106,259
+36,796
+53% +$17K

Similar funds

Jeff Yass's Q4 2023 Portfolio in Review

As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
  • Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
  • Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
  • Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
  • Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
  • Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
  • Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.